163 related articles for article (PubMed ID: 1846021)
21. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity.
Hüsken-Hindi P; Tsuchida K; Park M; Corrigan AZ; Vaughan JM; Vale WW; Fischer WH
J Biol Chem; 1994 Jul; 269(30):19380-4. PubMed ID: 8034704
[TBL] [Abstract][Full Text] [Related]
22. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or interleukin 6 in vitro.
Hedger MP; Phillips DJ; de Kretser DM
Cytokine; 2000 Jun; 12(6):595-602. PubMed ID: 10843734
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the activin receptor in cultured rat hepatocytes.
Zhang YQ; Kanzaki M; Mashima H; Mine T; Kojima I
Hepatology; 1996 Aug; 24(2):446-50. PubMed ID: 8690418
[TBL] [Abstract][Full Text] [Related]
24. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures.
Centrella M; Rosen V; Wozney JM; Casinghino SR; McCarthy TL
J Cell Biochem; 1997 Dec; 67(4):528-40. PubMed ID: 9383711
[TBL] [Abstract][Full Text] [Related]
25. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
26. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
27. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
Xu J; McKeehan K; Matsuzaki K; McKeehan WL
J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768
[TBL] [Abstract][Full Text] [Related]
28. Multiple regulatory effects by transforming growth factor-beta on type I collagen levels in osteoblast-enriched cultures from fetal rat bone.
Centrella M; Casinghino S; Ignotz R; McCarthy TL
Endocrinology; 1992 Dec; 131(6):2863-72. PubMed ID: 1446624
[TBL] [Abstract][Full Text] [Related]
29. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
Chen Y; Lebrun JJ; Vale W
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12992-7. PubMed ID: 8917532
[TBL] [Abstract][Full Text] [Related]
30. Strain-dependent control of transforming growth factor-beta function in osteoblasts in an in vitro model: biochemical events associated with distraction osteogenesis.
Knoll BI; McCarthy TL; Centrella M; Shin J
Plast Reconstr Surg; 2005 Jul; 116(1):224-33. PubMed ID: 15988272
[TBL] [Abstract][Full Text] [Related]
31. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
[TBL] [Abstract][Full Text] [Related]
32. Identification of the two types of specific receptor for activin/EDF expressed on Friend leukemia and embryonal carcinoma cells.
Kondo S; Hashimoto M; Etoh Y; Murata M; Shibai H; Muramatsu M
Biochem Biophys Res Commun; 1989 Jun; 161(3):1267-72. PubMed ID: 2545199
[TBL] [Abstract][Full Text] [Related]
33. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of vascular endothelial cell growth by activin-A.
McCarthy SA; Bicknell R
J Biol Chem; 1993 Nov; 268(31):23066-71. PubMed ID: 8226823
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.
Centrella M; McCarthy TL; Canalis E
J Biol Chem; 1987 Feb; 262(6):2869-74. PubMed ID: 3469200
[TBL] [Abstract][Full Text] [Related]
37. Inhibin and activin regulate [3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro.
Hedger MP; Drummond AE; Robertson DM; Risbridger GP; de Kretser DM
Mol Cell Endocrinol; 1989 Jan; 61(1):133-8. PubMed ID: 2501119
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation.
Ramsdell JS
Endocrinology; 1991 Apr; 128(4):1981-90. PubMed ID: 2004614
[TBL] [Abstract][Full Text] [Related]
39. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.
Centrella M; McCarthy TL; Canalis E
Endocrinology; 1990 Jan; 126(1):39-44. PubMed ID: 2152868
[TBL] [Abstract][Full Text] [Related]
40. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin.
Miró F; Hillier SG
Endocrinology; 1996 Feb; 137(2):464-8. PubMed ID: 8593790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
